Mark Dmytruk Biography and Net Worth

Mark joined Ginkgo in November 2020 with 25 years of finance and executive leadership experience, primarily in the life sciences and diagnostics industries. Prior to Ginkgo, Mark held several executive roles at Syneos Health (formerly INCResearch / inVentiv Health), a $4.5B revenue global CRO serving the biopharma industry, including EVP Corporate Strategy & Development and President, Patient Outcomes division. Prior to Syneos, Mark was at Thermo Fisher Scientific from 2001 - 2011. As VP Corporate Development, Mark led the company’s M&A function, contributing to its industry-changing strategy and transformational growth. He was also VP Finance for the Athena Diagnostics business unit prior to its sale to Quest Diagnostics. Mark began his career at Ernst & Young in Canada. He holds a Bachelor of Commerce from the University of Alberta and an MBA from the Sloan School of Management at MIT.

What is Mark E. Dmytruk's net worth?: The estimated net worth of Mark E. Dmytruk is at least $744,054.45 as of April 2nd, 2024. Mr. Dmytruk owns 865,079 shares of Ginkgo Bioworks stock worth more than $744,054 as of April 27th. This net worth evaluation does not reflect any other assets that Mr. Dmytruk may own. Additionally, Mr. Dmytruk receives a salary of $465,250.00 as Insider at Ginkgo Bioworks. Learn More about Mark E. Dmytruk's net worth.
How old is Mark E. Dmytruk?: Mr. Dmytruk is currently 52 years old. There are 2 older executives and no younger executives at Ginkgo Bioworks. Learn More on Mark E. Dmytruk's age.
What is Mark E. Dmytruk's salary?: As the Insider of Ginkgo Bioworks Holdings, Inc., Mr. Dmytruk earns $465,250.00 per year. Learn More on Mark E. Dmytruk's salary.
How do I contact Mark E. Dmytruk?: The corporate mailing address for Mr. Dmytruk and other Ginkgo Bioworks executives is 955 Fifth Avenue, New York NY, 10075. Ginkgo Bioworks can also be reached via phone at 877-442-5362 and via email at [email protected]. Learn More on Mark E. Dmytruk's contact information.
Has Mark E. Dmytruk been buying or selling shares of Ginkgo Bioworks?: During the last ninety days, Mark E. Dmytruk has sold $53,727.45 in Ginkgo Bioworks stock. Most recently, Mark E. Dmytruk sold 51,169 shares of the business's stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $1.05, for a transaction totalling $53,727.45. Following the completion of the sale, the insider now directly owns 865,079 shares of the company's stock, valued at $908,332.95. Learn More on Mark E. Dmytruk's trading history.
Who are Ginkgo Bioworks' active insiders?: Ginkgo Bioworks' insider roster includes Barry Canton (Major Shareholder), Marijn Dekkers (Director), Mark Dmytruk (Insider), Christian Henry (Director), Jason Kelly (Insider), and Reshma Shetty (Insider). Learn More on Ginkgo Bioworks' active insiders.
Are insiders buying or selling shares of Ginkgo Bioworks?: In the last twelve months, Ginkgo Bioworks insiders bought shares 1 times. They purchased a total of 400,000 shares worth more than $512,000.00. In the last twelve months, insiders at the sold shares 71 times. They sold a total of 3,788,984 shares worth more than $26,732,779.17. The most recent insider tranaction occured on April, 2nd when insider Mark E Dmytruk sold 51,169 shares worth more than $53,727.45. Insiders at Ginkgo Bioworks own 15.1% of the company. Learn More about insider trades at Ginkgo Bioworks.
Information on this page was last updated on 4/2/2024.

Mark E. Dmytruk Insider Trading History at Ginkgo Bioworks

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/2/2024	Sell	51,169	$1.05	$53,727.45	865,079
2/2/2024	Sell	39,569	$1.21	$47,878.49	761,737
12/4/2023	Sell	42,402	$1.39	$58,938.78	676,844
10/2/2023	Sell	42,237	$1.76	$74,337.12	586,393
9/5/2023	Sell	41,417	$2.23	$92,359.91	543,585
8/2/2023	Sell	46,519	$2.07	$96,294.33	499,959
7/3/2023	Sell	40,637	$1.80	$73,146.60	461,432
6/2/2023	Sell	40,511	$1.56	$63,197.16	417,028
5/22/2023	Sell	250,000	$1.50	$375,000.00	372,495
4/10/2023	Sell	740	$1.33	$984.20	576,254
3/15/2023	Sell	29,762	$1.31	$38,988.22	530,736
1/4/2023	Sell	34,588	$1.56	$53,957.28	454,549
11/3/2022	Sell	30,604	$2.65	$81,100.60	384,074

Mark E. Dmytruk Buying and Selling Activity at Ginkgo Bioworks

Ginkgo Bioworks Company Overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $0.86

$0.76

$0.87

50 Day Range

MA: $1.13

$0.78

$1.54

2 Week Range

Now: $0.86

$0.74

$2.55

Volume

71,222,534 shs

Average Volume

31,559,994 shs

Market Capitalization

$1.85 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>

Mark Dmytruk Biography and Net Worth

What is Mark E. Dmytruk's net worth?

How old is Mark E. Dmytruk?

What is Mark E. Dmytruk's salary?

How do I contact Mark E. Dmytruk?

Has Mark E. Dmytruk been buying or selling shares of Ginkgo Bioworks?

Who are Ginkgo Bioworks' active insiders?

Are insiders buying or selling shares of Ginkgo Bioworks?